FDA Advisers Endorse Pfizer COVID Booster Only For Those 65 And Over Or At Risk

An independent committee of experts has recommended that the Food and Drug Administration should not allow Pfizer to provide a third dose of its COVID-19 vaccine to Americans older than 16.